JSPR
Jasper Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.22
-0.05 ▼ -3.94%
🌙 3월 13일 7:57 PM ET (한국 3/14 08:57)
$1.22
+0.00 -0.29%
| Index | - | P/E | - | EPS (ttm) | -5.9 | Insider Own | 13.71% | Shs Outstand | 0.03B | Perf Week | -11.59% |
| Market Cap | 0.03B | Forward P/E | - | EPS next Y | 42.67% | Insider Trans | 3.87% | Shs Float | 0.02B | Perf Month | -1.61% |
| Enterprise Value | -0.02B | PEG | - | EPS next Q | -0.71 | Inst Own | 60.49% | Short Float | 13.83% | Perf Quarter | -34.76% |
| Income | -0.09B | P/S | - | EPS this Y | 13.92% | Inst Trans | -7.21% | Short Ratio | 4.94 | Perf Half Y | -52.34% |
| Sales | 0.00B | P/B | 2.95 | EPS next 5Y | 27.4% | ROA | -116.04% | Short Interest | 3.34M | Perf YTD | -33.33% |
| Book/sh | 0.41 | P/C | 0.67 | EPS past 3/5Y | 43.36% 54.53% | ROE | -191.12% | 52W High | -83.03% ($7.19) | Perf Year | -77.32% |
| Cash/sh | 1.82 | P/FCF | - | Sales past 3/5Y | - | ROIC | -786.63% | 52W Low | 9.91% ($1.11) | Perf 3Y | -93.3% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -24.38% | Gross Margin | - | Volatility(W/M) | 7.57% 8.16% | Perf 5Y | -98.77% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.1 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 2.59 | EPS Q/Q | 9.35% | Profit Margin | - | RSI (14) | 38.79 | Recom | 1.57 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.59 | Sales Q/Q | - | SMA20 | -8.51% ($1.33) | Beta | 3.1 | Target Price | $11.8 |
| Payout | - | Debt/Eq | 0.15 | Earnings | 11000000 | SMA50 | -16.42% ($1.46) | Rel Volume | 0.57 | Prev Close | $1.27 |
| Employees | 64 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 6.99% - | SMA200 | -53.25% ($2.61) | Avg Volume(3M) | 0.68M | Price | $1.22 |
| IPO | 2020/1/10 | Option/Short | Yes/Yes | Trades | 1340 | Volume | 385,330 | Change | -3.94% |
뉴스 로딩 중...